The social value of fluphenazine decanoate
Stevens, B.
Acta Psychiatrica Belgica 76(5): 792-804
1976
ISSN/ISBN: 0300-8967 PMID: 799897 Document Number: 107639
The Medical Research Council (England) conducted a double blind placebo controlled trial of fluphenazine decanoate as a form of maintenance therapy for schizophrenic out-patients. The results clearly demonstrated the clinical and social value of the drug in minimizing positive psychotic features, in preventing relapse and thereby alleviating distress amongst the parents of single patients and the wives of married patients. The drug allows the patients to fulfill normal social role expectations.